First malaria vaccine to be tested in pilot projects, WHO announcesBMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i6212 (Published 21 November 2016) Cite this as: BMJ 2016;355:i6212
- Anne Gulland
The world’s first malaria vaccine will be introduced in pilot projects in sub-Saharan Africa from 2018, the World Health Organisation (WHO) has said.
The vaccine, known as RTS,S acts against Plasmodium falciparum, the parasite associated with the highest rates of malaria complications and deaths, and the most common in sub-Saharan Africa.
After a phase 3 trial last year showed that the vaccine reduced the risk of clinical malaria by around 30% in infants and children,1 two WHO expert advisory committees advised that it be tested before being recommended for widespread use.2
WHO will announce which three …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial